69
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Synchronous Neoplastic Lesions In Referred Patients With Colorectal Cancer: A Retrospective Cohort Study

, , , , , , & show all
Pages 9951-9959 | Published online: 26 Nov 2019

References

  • Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927 ):1490–1502. doi:10.1016/S0140-6736(13)61649-924225001
  • Talbot R, Kirkham S. Colorectal cancer. Lancet. 2010;376(9738 ):330. doi:10.1016/S0140-6736(10)61182-820674717
  • Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6 ):366–378. doi:10.3322/caac.2003819897840
  • Bosetti C, Levi F, Rosato V, et al. Recent trends in colorectal cancer mortality in Europe. Int J Cancer. 2011;129(1 ):180–191. doi:10.1002/ijc.v129.120824701
  • Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol. 2012;23(10 ):2755–2762. doi:10.1093/annonc/mds06922492700
  • Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50(1 ):113–130. doi:10.1111/his.2007.50.issue-117204026
  • Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8 ):687–696. doi:10.1056/NEJMoa110037022356322
  • Borda A, Martínez-Peñuela JM, Muñoz-Navas M, Prieto C, Betés M, Borda F. [Synchronous neoplastic lesions in colorectal cancer. An analysis of possible risk factors favouring presentation]. Rev Esp Enferm Dig. 2008;100(3 ):139–145. doi:10.4321/s1130-0108200800030000318416638
  • Pinol V, Andreu M, Castells A, et al. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum. 2004;47(7 ):1192–1200. doi:10.1007/s10350-004-0562-715164252
  • Erenay FS, Alagoz O, Banerjee R, Cima RR. Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation. Med Decis Making. 2011;31(4 ):611–624. doi:10.1177/0272989X1039180921212440
  • Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143(3 ):844–857. doi:10.1053/j.gastro.2012.06.00122763141
  • Gao Q, Tsoi KK, Hirai HW, et al. Serrated polyps and the risk of synchronous colorectal advanced neoplasia: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(4 ):501–509. doi:10.1038/ajg.2015.4925756237
  • Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113(10 ):779–788. doi:10.7326/0003-4819-113-10-7792240880
  • Myer PA, Mannalithara A, Singh G, Ladabaum U. Proximal and distal colorectal cancer resection rates in the United States since widespread screening by colonoscopy. Gastroenterology. 2012;143(5 ):1227–1236. doi:10.1053/j.gastro.2012.07.10722841786
  • Missiaglia E, Jacobs B, D’Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25(10 ):1995–2001. doi:10.1093/annonc/mdu27525057166
  • O’Sullivan B, Brierley J, Byrd D, et al. The TNM classification of malignant tumours-towards common understanding and reasonable expectations. Lancet Oncol. 2017;18(7 ):849–851. doi:10.1016/S1470-2045(17)30438-228677562
  • Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343(3 ):169–174. doi:10.1056/NEJM20000720343030210900275
  • Lieberman D, Moravec M, Holub J, Michaels L, Eisen G. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology. 2008;135(4 ):1100–1105. doi:10.1053/j.gastro.2008.06.08318691580
  • Jayasekara H, Reece JC, Buchanan DD, et al. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: a prospective cohort study. Int J Cancer. 2016;139(5 ):1081–1090. doi:10.1002/ijc.3015327098183
  • Strum WB. Colorectal adenomas. N Engl J Med. 2016;374(11 ):1065–1075. doi:10.1056/NEJMra151358126981936
  • Vleugels JLA, Hazewinkel Y, Fockens P, Dekker E. Natural history of diminutive and small colorectal polyps: a systematic literature review. Gastrointest Endosc. 2017;85(6 ):1169–1176.e1. doi:10.1016/j.gie.2016.12.01428024986
  • Lieberman DA, Holub JL, Morris CD, Logan J, Williams JL, Carney P. Low rate of large polyps (>9 mm) within 10 years after an adequate baseline colonoscopy with no polyps. Gastroenterology. 2014;147(2 ):343–350. doi:10.1053/j.gastro.2014.04.02024768680
  • Abu Dayyeh BK, Thosani N; ASGE Technology Committee, et al. ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc. 2015;81(3 ):502.e1-502.e16. doi:10.1016/j.gie.2014.12.022
  • Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150(1 ):1–8. doi:10.7326/0003-4819-150-1-200901060-0030619075198
  • Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154(1 ):22–30. doi:10.7326/0003-4819-154-1-201101040-0000421200035
  • Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol. 2008;6(9 ):1011–1015. doi:10.1016/j.cgh.2008.03.02218558514
  • Liao X, Lochhead P, Nishihara R, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012;367(17 ):1596–1606. doi:10.1056/NEJMoa120775623094721
  • Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348(10 ):891–899. doi:10.1056/NEJMoa02173512621133
  • Benamouzig R, Deyra J, Martin A, et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology. 2003;125(2 ):328–336. doi:10.1016/S0016-5085(03)00887-412891533
  • Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348(10 ):883–890. doi:10.1056/NEJMoa02163312621132
  • Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology. 2008;134(1 ):29–38. doi:10.1053/j.gastro.2007.10.01418022173
  • Ishikawa H, Mutoh M, Suzuki S, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut. 2014;63(11 ):1755–1759. doi:10.1136/gutjnl-2013-30582724488498